Mon.Oct 11, 2021

Sarepta outlines final push for Duchenne gene therapy

Bio Pharma Dive

The biotech still believes a speedy approval filing for the closely watched treatment is possible, but expects to have to wait for the results of the recently launched Phase 3 trial, CEO Doug Ingram said on a conference call

DTC is evolving: 10 things you must do

World of DTC Marketing

SUMMARY : DTC marketing is evolving as patients become more thoughtful about choosing treatment options. The model of “heavy TV followed by a website designed to sell people isn’t going to work anymore.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

eCOA clinical trials: A simple, cost-effective approach to study build

Bio Pharma Dive

This new data capture model gives clinical trial sponsors control over study build

Samsung Biologics to help Enzolytics advance clinical development of mAbs

BioPharma Reporter

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing

Adamas, Flexion sell for $825M combined as biotech's dealmaking pace picks up

Bio Pharma Dive

After lagging for months, M&A has accelerated over the past five weeks. But the average size of each transaction remains low compared to past years, as evidenced by the dual Monday buyouts of Adamas and Flexion

177
177

Pfizer-BioNTech Lead Globally with COVID-19 Vaccine

BioSpace

Although there are many effective and safe COVID-19 vaccines around the world, the preferred vaccine is the Pfizer-BioNTech vaccine. For that and more stories, read on

Merck, Ridgeback seek US clearance of first oral COVID-19 drug

Bio Pharma Dive

The two partners have officially filed for emergency authorization of their antiviral pill, a milestone in the fight against COVID-19. It's not yet clear whether vaccine recipients will be eligible for treatment, however

More Trending

New Evidence Suggests COVID-19 Vaccines Might Mitigate Long COVID

BioSpace

Evidence is emerging that not only can COVID-19 vaccines help to prevent the condition, but they could serve as a form of “rescue” for those already stricken with it

‘Build back better’ cannot mean longer waiting times for change

Pharma Phorum

Global Blood Therapeutics (GBT) UK general manager Nigel Nicholls discusses the impact of COVID-19 for sickle cell patients in the UK. If the COVID-19 pandemic has shown us anything, it has highlighted the extent to which health inequity plagues our society.

Merck Asks F.D.A. for Emergency Approval of Covid Pill

NY Times

The company is seeking authorization for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be eligible. Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Molnupiravir Merck & Company Inc Food and Drug Administration Vaccination and Immunization

Drugs 83

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

BioSpace

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day

NICE backs Rinvoq for moderate active RA

Pharma Times

Decision expands access to oral therapy to around 27,000 people in England

82

New study sheds light on molecular motion

Scienmag

New research has shown how a synthetic self-made fibres can guide molecular movement that can be fuelled by light over long distances, a discovery that could pave the way for new ways to use light as a source of sustainable energy.

Medtech firm Entia raises $12m for ‘virtual oncology solution’

Pharma Times

Virtual monitoring service enable patients to perform their own at-home blood tests

82

Mastering data management can lead to improved outcomes: CitiusTech

Outsourcing Pharma

According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care. Clinical Development

Exploring How COVID-19 Has Accelerated Digital in Healthcare: A Re-cap of the PMN Innovation Summit

Pharma Marketing Network

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Present.

Vifor Pharma announces changes to its Executive Committee

BioTech 365

Vifor Pharma announces changes to its Executive Committee Vifor Pharma announces changes to its Executive Committee Executive committee members Lee Heeson and Gregory Oakes to leave the company for personal reasons Succession planning ongoing ST.

52

Are You on a Medicare Cliff? Finding Out Can Save You Money.

Triage Cancer

If you are on Medicare, but have a higher income level, you might be on the edge of a “cliff” without knowing it. What is a Medicare cliff? Medicare Part B monthly premiums are what you pay each month to have coverage. Premiums are based on your income level from 2 years ago.

52

Gerresheimer AG: Gerresheimer on growth course

BioTech 365

DGAP-News: Gerresheimer AG / Key word(s): Quarter Results/9 Month figures 12.10.2021 / 07:00 The issuer is solely responsible for the content of this announcement.

52

Chemists discover faster-acting forms of insecticide imidacloprid

Scienmag

Scientists have developed seven crystal forms of imidacloprid—one of the world’s most widely used insecticides—in an effort to sharply reduce its environmental impact, according to a study published in the Journal of the American Chemical Society.

GenSight Biologics Announces FDA Grant of Fast Track Designation for Optogenetic Therapy GS030 as Treatment for Retinitis Pigmentosa

BioTech 365

52

OPTIMA: New research project aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence

Scienmag

Biognosys Supports Cancer Scout, a Large-Scale Multi-Omics Research Project to Accelerate Personalized Cancer Medicine

BioTech 365

Research at Romark: A caution for clinical research sites about Sponsors whom are unable to pay

Clinical Trial Gurus

Imagine you are a site owner and are doing one of your first clinical trials, invest your life savings into recruiting and staffing costs for your new business and then the sponsor never pays!

MiNA Therapeutics Expands Senior Leadership Team With Four New Hires to Support Next Phase of Growth

BioTech 365

MiNA Therapeutics Expands Senior Leadership Team With Four New Hires to Support Next Phase of Growth MiNA Therapeutics Expands Senior Leadership Team With Four New Hires to Support Next Phase of Growth Including Troels Koch who brings over 20 years … Continue reading → Business Wire

52

Ocean life helps produce clouds, but existing clouds keep new ones at bay

Scienmag

MADISON, Wis. Stand on the ocean’s shore and take a big whiff of the salt spray and you’ll smell the unmistakably pungent scent of the sea. That ripe, almost rotting smell? That’s sulfur. Credit: Sam Hall MADISON, Wis. Stand on the ocean’s shore and take a big whiff of the salt spray and […].

52

EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Andrew X. Zhu

BioTech 365

EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Andrew X. Zhu EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Andrew X.

Forgiveness messaging increases willingness to accept former Boko Haram fighters returning home, new study shows

Scienmag

(Washington, DC) Demobilized Boko Haram militants facing reintegration might be helped by supportive messaging from religious leaders, according to a study released today.

52

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call

BioTech 365

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call Conference Call to be on Monday, October 25, … Continue reading → Business Wire

52

Automatic entry into career advancing competitions could help women, study suggests

Scienmag

Toronto – Women continue to be underrepresented in leadership roles, a dilemma a new study suggests could be helped by eliminating self-nomination from competitive selection processes.

52

DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit

BioTech 365

DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.

52

Driving Innovation in Pharmaceutical Commercialization

Pharma Marketing Network

By Shetal Vyas, MBA, Vice President, Operations, Ferring Pharmaceuticals. In the wake of the COVID-19 pandemic, the importance of getting the right medicines and therapies into the hands of patients has never been clearer.

Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology

BioTech 365

Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology Analyses Suggest Survival Benefit Associated with … Continue reading → Business Wire

52

Man’s best friend could be a jaguar’s next meal: A case study from the Mexican Caribbean

Scienmag

Mahahual is a small fishing village in the Mexican Caribbean that receives a large number of tourists every year.

52

New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis

BioTech 365

New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis Findings to be shared in oral presentation at … Continue reading → Business Wire

Antibody delivery technology empowers immunotherapy against glioblastoma and suppresses side effects

Scienmag

Summary: •An antibody delivery technology was developed based on multiple glucosylated polymers conjugated onto antibodies via linkers cleaving in tumor microenvironment.

Parse Biosciences Extends RNA-Seq Kit Reach to Australia and New Zealand through Decode Sciences Agreement

BioTech 365

RNA 52